Sign in
4

Changes in Ownership

Perspective Therapeutics, Inc. Filed Acc 0000950170-25-048775

Chief Executive Officer bought 26,676 shares at an average $2.24 ($59,673)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Spoor Johan M. Chief Executive Officer 2025-03-28 Purchase +22,026 $2.24 $49,384 59,383 D
Spoor Johan M. Chief Executive Officer 2025-03-28 Purchase +4,650 $2.21 $10,288 4,650 I
Open-market purchases · 26,676 sh · avg $2.24 · $59,673
Loading xslF345X05/ownership.xml…